We determined the relevant variables that affect downstream MAPK and PI3K signaling and presented a unified model that enabled us to assess the effect of single and combination treatments and to predict the resulting proliferative behavior in cell lines representing three subtypes of breast cancer. Here, PIK3CA is linked to breast cancer.